N. Zhu, D. Zhang, W. Wang, X. Li, B. Yang et al., A Novel Coronavirus from Patients with Pneumonia in China, 2019, New England Journal of Medicine, vol.382, issue.8, pp.727-733, 2020.

R. Wölfel, V. M. Corman, W. Guggemos, M. Seilmaier, S. Zange et al., Virological assessment of hospitalized patients with COVID-2019, Nature, vol.581, issue.7809, pp.465-469, 2020.

T. C. Niemeyer, P. Jones, C. Vollmar, M. Rothe, T. Hoelscher et al.,

R. Schneider, K. Ehmann, C. Zwirglmaier, C. Drosten, and . Wendtner, Virological assessment 319 of hospitalized patients with COVID-2019, Nature, 2020.

R. Wölfel, V. M. Corman, W. Guggemos, M. Seilmaier, S. Zange et al., Virological assessment of hospitalized patients with COVID-2019, Nature, vol.581, issue.7809, pp.465-469, 2020.

R. W. Peeling, C. J. Wedderburn, P. J. Garcia, D. Boeras, N. Fongwen et al., Serology testing in the COVID-19 pandemic response, The Lancet Infectious Diseases, vol.20, issue.9, pp.e245-e249, 2020.

A. Sall, D. L. Tanuri, and . Heymann, Serology testing in the COVID-19 pandemic response, The 323 Lancet Infectious Diseases, p.147330992030517, 2020.

R. W. Peeling, C. J. Wedderburn, P. J. Garcia, D. Boeras, N. Fongwen et al., Serology testing in the COVID-19 pandemic response, The Lancet Infectious Diseases, vol.20, issue.9, pp.e245-e249, 2020.

I. Eckerle and B. Meyer, SARS-CoV-2 seroprevalence in COVID-19 hotspots, The Lancet, vol.326, pp.31482-31485, 2020.

Y. Tan, C. Yan, and C. Guo, Management of patients with suspected COVID-19 who underwent emergency surgery, WHO, 2020.

R. Lassaunière, A. Frische, Z. B. Harboe, A. C. Nielsen, A. Fomsgaard et al., Evaluation of nine commercial SARS-CoV-2 immunoassays, 2020.

. Jørgensen, Evaluation of nine commercial SARS-CoV-2 immunoassays, Infectious 332 Diseases (except HIV/AIDS), 2020.

J. Van-elslande, E. Houben, M. Depypere, A. Brackenier, S. Desmet et al., Diagnostic performance of seven rapid IgG/IgM antibody tests and the Euroimmun IgA/IgG ELISA in COVID-19 patients, Clinical Microbiology and Infection, vol.26, issue.8, pp.1082-1087, 2020.

K. Ranst, P. Lagrou, and . Vermeersch, Diagnostic performance of seven rapid IgG/IgM 335 antibody tests and the Euroimmun IgA/IgG ELISA in COVID-19 patients, Clin. Microbiol

K. G. Beavis, S. M. Matushek, A. P. Abeleda, C. Bethel, C. Hunt et al.,

. Tesic, Evaluation of the EUROIMMUN Anti-SARS-CoV-2 ELISA Assay for detection of IgA 339 and IgG antibodies, J. Clin. Virol, vol.129, p.104468, 2020.

K. G. Beavis, S. M. Matushek, A. P. Abeleda, C. Bethel, C. Hunt et al., Evaluation of the EUROIMMUN Anti-SARS-CoV-2 ELISA Assay for detection of IgA and IgG antibodies, Journal of Clinical Virology, vol.129, p.104468, 2020.

A. J. Jääskeläinen, S. Kuivanen, E. Kekäläinen, M. J. Ahava, R. Loginov et al., Performance of six SARS-CoV-2 immunoassays in comparison with microneutralisation, 2020.

H. Vapalahti, S. Jarva, M. Kurkela, and . Lappalainen, Performance of six SARS-CoV-2

, immunoassays in comparison with microneutralisation, J. Clin. Virol, vol.129, p.104512, 2020.

T. Nicol, C. Lefeuvre, O. Serri, A. Pivert, F. Joubaud et al., Assessment of SARS-CoV-2 serological tests for the diagnosis of COVID-19 through the evaluation of three immunoassays: Two automated immunoassays (Euroimmun and Abbott) and one rapid lateral flow immunoassay (NG Biotech), Journal of Clinical Virology, vol.129, p.104511, 2020.

F. Ducancelle, H. L. Lunel-fabiani, and . Guillou-guillemette, Assessment of SARS-CoV-2 347 serological tests for the diagnosis of COVID-19 through the evaluation of three 348 immunoassays: Two automated immunoassays (Euroimmun and Abbott) and one rapid 349 21 lateral flow immunoassay (NG Biotech), J. Clin. Virol, vol.129, p.104511, 2020.

N. Kohmer, S. Westhaus, C. Rühl, S. Ciesek, and H. F. Rabenau, Clinical performance of SARS-CoV-2 IgG antibody tests and potential protective immunity, J. Med. Virol, 2020.

N. Kohmer, S. Westhaus, C. Rühl, S. Ciesek, and H. F. Rabenau, Clinical performance of different SARS?CoV?2 IgG antibody tests, Journal of Medical Virology, vol.92, issue.10, pp.2243-2247, 2020.

I. Montesinos, D. Gruson, B. Kabamba, H. Dahma, S. Van-den-wijngaert et al., Evaluation of two automated and three rapid lateral flow immunoassays for the detection of anti-SARS-CoV-2 antibodies, Journal of Clinical Virology, vol.128, p.104413, 2020.

O. Carbone, B. Vandenberg, F. Gulbis, H. Wolff, and . Rodriguez-villalobos, Evaluation of two 356 automated and three rapid lateral flow immunoassays for the detection of

J. Denner, SARS-CoV-2 and enhancing antibodies, Journal of Clinical Virology, vol.128, p.104424, 2020.

N. Kohmer, S. Westhaus, C. Rühl, S. Ciesek, and H. F. Rabenau, Brief clinical evaluation of six high-throughput SARS-CoV-2 IgG antibody assays, Journal of Clinical Virology, vol.129, p.104480, 2020.

A. Krüttgen, C. G. Cornelissen, M. Dreher, M. Hornef, M. Imöhl et al., Comparison of four new commercial serologic assays for determination of SARS-CoV-2 IgG, Journal of Clinical Virology, vol.128, p.104394, 2020.

. Virol, , vol.128, p.104394, 2020.

L. Weidner, S. Gänsdorfer, S. Unterweger, L. Weseslindtner, C. Drexler et al., Quantification of SARS-CoV-2 antibodies with eight commercially available immunoassays, Journal of Clinical Virology, vol.129, p.104540, 2020.

E. Witt, P. Schistal, T. R. Schlenke, C. Kreil, and . Jungbauer, Quantification of SARS-CoV-2 367 antibodies with eight commercially available immunoassays, J. Clin. Virol, vol.129, 2020.

B. Meyer, G. Torriani, S. Yerly, L. Mazza, A. Calame et al., Validation of a commercially available SARS-CoV-2 serological Immunoassay, 2020.

J. Agoritsas, H. Stirnemann, I. Spechbach, S. Guessous, J. Stringhini et al., , p.371

L. Lombard, C. Fontao, I. Siegrist, N. Eckerle, L. Vuilleumier et al., , p.372

B. Meyer, G. Torriani, S. Yerly, L. Mazza, A. Calame et al., Validation of a commercially available SARS-CoV-2 serological Immunoassay, Clin. Microbiol. Infect, 2020.

B. Meyer, G. Torriani, S. Yerly, L. Mazza, A. Calame et al., Validation of a commercially available SARS-CoV-2 serological immunoassay, Clinical Microbiology and Infection, vol.26, issue.10, pp.1386-1394, 2020.

E. Tuaillon, K. Bolloré, A. Pisoni, S. Debiesse, C. Renault et al., Detection of SARS-CoV-2 antibodies using commercial assays and seroconversion patterns in hospitalized patients, Journal of Infection, vol.81, issue.2, pp.e39-e45, 2020.
URL : https://hal.archives-ouvertes.fr/hal-02862130

A. Pansu, D. Dupuy, V. Morquin, A. Foulongne, V. L. Bourdin et al., 377 Detection of SARS-CoV-2 antibodies using commercial assays and seroconversion 378 patterns in hospitalized patients, Journal of Infection, 2020.

C. H. Geurtsvankessel, N. M. Okba, Z. Igloi, C. W. Embregts, B. M. Laksono et al., Towards the next phase: evaluation of serological assays for diagnostics and exposure assessment., p.381, 2020.

L. Leijten, C. Rokx, B. Rijnders, J. Rahamat-langendoen, J. P. Van-den-akker et al., , p.382

A. A. Kampen, R. S. Van-der-eijk, B. Van-binnendijk, M. Haagmans, and . Koopmans, An 383 evaluation of COVID-19 serological assays informs future diagnostics and exposure 384 assessment, Nature Communications, vol.11, p.3436, 2020.

E. S. Theel, J. Harring, H. Hilgart, and D. Granger, Performance Characteristics of Four High-Throughput Immunoassays for Detection of IgG Antibodies against SARS-CoV-2, Journal of Clinical Microbiology, vol.58, issue.8, 2020.

. Microbiol, , 2020.

K. L. Chew, S. S. Tan, S. Saw, A. Pajarillaga, S. Zaine et al., Clinical evaluation of serological IgG antibody response on the Abbott Architect for established SARS-CoV-2 infection, Clinical Microbiology and Infection, vol.26, issue.9, pp.1256.e9-1256.e11, 2020.

S. K. Jureen and . Sethi, Clinical evaluation of serological IgG antibody response on the 391

K. Harley and I. Gunsolus, Comparison of the Clinical Performance of the Abbott Alinity IgG, Abbott Architect IgM, and Roche Elecsys Total SARS-CoV-2 Antibody Assays, Journal of Clinical Microbiology, 2020.

S. Meschi, F. Colavita, L. Bordi, G. Matusali, D. Lapa et al., Performance evaluation of Abbott ARCHITECT SARS-CoV-2 IgG immunoassay in comparison with indirect immunofluorescence and virus microneutralization test, Journal of Clinical Virology, vol.129, p.104539, 2020.

M. R. Capobianchi and C. Castilletti, INMICovid-19 laboratory team, Performance evaluation 395 of Abbott ARCHITECT SARS-CoV-2 IgG immunoassay in comparison with indirect, vol.396, p.23

J. Zhao, Q. Yuan, H. Wang, W. Liu, X. Liao et al., Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019, 2020.

F. Hong, Y. Wang, Z. Liu, Q. Wang, Z. He et al., , p.400

Z. Zhang, Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 401 2019, Infectious Diseases, p.2020

J. Zhao, Q. Yuan, H. Wang, W. Liu, X. Liao et al., Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019, 2020.

D. S. Ong, S. J. De-man, F. A. Lindeboom, and J. G. Koeleman, Comparison of diagnostic accuracies of rapid serological tests and ELISA to molecular diagnostics in patients with suspected coronavirus disease 2019 presenting to the hospital, Clinical Microbiology and Infection, vol.26, issue.8, pp.1094.e7-1094.e10, 2020.

E. Brochot, B. Demey, A. Touzé, S. Belouzard, J. Dubuisson et al., Anti-spike, Anti-nucleocapsid and Neutralizing Antibodies in SARS-CoV-2 Inpatients and Asymptomatic Individuals, Frontiers in Microbiology, vol.11, 2020.

S. Francois, F. Castelain, and . Helle, Anti-Spike, anti-Nucleocapsid and neutralizing antibodies 409 in SARS-CoV-2 inpatients and asymptomatic carriers, Infectious Diseases, p.410

E. Brochot, B. Demey, A. Touze, S. Belouzard, J. Dubuisson et al., Anti-Spike, anti-Nucleocapsid and neutralizing antibodies in SARS-CoV-2 inpatients and asymptomatic carriers, HIV/AIDS), 2020.

C. Schnurra, N. Reiners, R. Biemann, T. Kaiser, H. Trawinski et al., Comparison of 412 the diagnostic sensitivity of SARS-CoV-2 nucleoprotein and glycoprotein-based antibody 413 tests, J. Clin. Virol, vol.129, 2020.

B. Sun, Y. Feng, X. Mo, P. Zheng, Q. Wang et al., Kinetics of SARS-CoV-2 specific IgM and IgG responses in COVID-19 patients, Emerging Microbes & Infections, vol.9, issue.1, pp.940-948, 2020.

W. Zhang, X. Luo, P. Niu, L. Hu, H. Wang et al.,

L. Zhong and . Chen, Kinetics of SARS-CoV-2 specific IgM and IgG responses in COVID-19 417 patients, Emerg Microbes Infect, vol.9, pp.940-948, 2020.

B. Sun, Y. Feng, X. Mo, P. Zheng, Q. Wang et al., Kinetics of SARS-CoV-2 specific IgM and IgG responses in COVID-19 patients, Emerging Microbes & Infections, vol.9, issue.1, pp.940-948, 2020.

S. Fafi-kremer, T. Bruel, Y. Madec, R. Grant, L. Tondeur et al., Serologic responses to SARS-CoV-2 infection among hospital staff with mild disease in eastern France, p.420, 2020.

P. Souque, S. Fernandes-pellerin, N. Jolly, and C. Renaudat,

N. Mutter, A. Collongues, A. Bolle, N. Velay, M. Lefebvre et al., , p.422

P. Charneau, B. Hoen, J. De-seze, O. Schwartz, and A. Fontanet, Serologic responses to 423 SARS-CoV-2 infection among hospital staff with mild disease in eastern France, p.424

. Ebiomedicine, , p.102915, 2020.

G. Rijkers, J. Murk, B. Wintermans, B. Van-looy, M. Van-den-berge et al., Differences in antibody kinetics and functionality between severe and mild SARS-CoV-2 infections., 2020.

C. Stohr, P. Reusken, J. Van-der-pol, and . Reimerink, Differences in antibody kinetics and 427 functionality between severe and mild SARS-CoV-2 infections, The Journal of Infectious, vol.428

. Diseases, , p.463, 2020.

S. J. Pallett, M. Rayment, A. Patel, E. Charani, S. J. Denny et al., Serological assays for delayed SARS-CoV-2 case identification ? Author's reply, The Lancet Respiratory Medicine, vol.8, issue.10, p.e74, 2020.

K. C. Mai, J. Gilmour, C. Hatcher, P. Scott, N. Randell et al., , p.431

G. W. Davies, Point-of-care serological assays for delayed SARS-CoV-2 case identification 432 among health-care workers in the UK: a prospective multicentre cohort study, The 433 Lancet Respiratory Medicine, p.2213260020303155, 2020.

, , pp.30315-30320

S. Brandstetter, S. Roth, S. Harner, H. Buntrock-döpke, A. A. Toncheva et al.,

A. Gruber, M. Ambrosch, and . Kabesch, Symptoms and immunoglobulin development in 437 hospital staff exposed to a SARS-CoV-2 outbreak, Pediatric Allergy and Immunology, p.438